# I Peace, Inc.

> I Peace, Inc. is a Palo Alto- and Kyoto-based biotech that mass-manufactures clinical-grade induced pluripotent stem cells (iPSCs) using a proprietary automated, closed-cassette platform. Founded in 2015 by Koji Tanabe - a co-author of the world's first human iPSC paper from Shinya Yamanaka's Nobel Prize-winning lab - the company operates as a CDMO supplying GMP-grade iPSCs to pharmaceutical companies, biotechs, and research institutions, and offers personal iPSC banking and longevity services that aim to make cell therapy affordable and accessible.

- **Founded:** 2015
- **Headquarters:** Palo Alto, California, United States
- **Founders:** Koji Tanabe (Founder & CEO)
- **Team size:** ~16 employees
- **Products:** GMP iPSC Manufacturing (CDMO), Research-Grade iPSCs & Drug Discovery Services, Automated iPSC Manufacturing Platform, My Peace - Personal iPSC Banking, Longevity & Rejuvenation Therapies
- **Notable:** Developed a proprietary closed, automated, palm-sized cassette system for mass-producing clinical-grade iPSCs, Received a license to manufacture clinical-grade cells from Japan's Ministry of Health, Labour and Welfare on March 11, 2020, US FDA drug establishment registration

## Products & services

- **GMP iPSC Manufacturing (CDMO)** — Custom manufacturing of clinical-grade, cGMP-compliant induced pluripotent stem cells for pharmaceutical and biotech partners, conforming to US and Japanese regulatory standards.
- **Research-Grade iPSCs & Drug Discovery Services** — Research-grade iPS cells and differentiated cell products for drug discovery and life-science research.
- **Automated iPSC Manufacturing Platform** — Proprietary closed, palm-sized cassette system using robotics and fluidics to mass-produce multiple discrete iPS cell lines simultaneously, reducing contamination risk and cost.
- **My Peace - Personal iPSC Banking** — Personal production and cryopreservation of an individual's own youthful iPS cells for future regenerative and longevity use.
- **Longevity & Rejuvenation Therapies** — Personalized treatments using age-reversed cells and their components, launched in the US in April 2025.

## Achievements

- Developed a proprietary closed, automated, palm-sized cassette system for mass-producing clinical-grade iPSCs
- Received a license to manufacture clinical-grade cells from Japan's Ministry of Health, Labour and Welfare on March 11, 2020
- US FDA drug establishment registration
- Manufactured 100 GMP-grade iPS cell lines cumulatively as of January 2025
- ISO/IEC 17025 certified
- Founder Koji Tanabe named to World Biz Magazine's Top 100 Innovation CEO list (2021)
- Launched personalized iPS cell services and longevity therapies in the US in April 2025

## Latest updates

- **2025-05** — Strategic alliance with FUNROOTS and Reju announced.
- **2025-04** — Launched personalized iPS cell services and longevity therapies in the United States.
- **2025-01** — Reached 100 cumulative GMP-grade iPS cell lines manufactured.
- **2022-11** — Partnered with CIRM as an Industry Resource Partner to supply GMP iPSCs.

## Links

- Website: https://ipeace.com
- LinkedIn: http://www.linkedin.com/company/i-peace-inc.
- Twitter/X: https://twitter.com/IPeaceInc_J
- Instagram: https://www.instagram.com/mypeace_ips/
- Facebook: https://www.facebook.com/ipeace.inc

---

Profile page: https://yespress.io/i-peace-inc-ipsc-platform-for-longevity-and-cell-therapy-creating-future-health
Published by YesPress — https://yespress.io
Last updated: 2026-06-14